VectorY Appoints Seasoned Biotech Leader Adam Rosenberg as Chair of the Board [Yahoo! Finance]
Eliem Therapeutics, Inc (ELYM)
Company Research
Source: Yahoo! Finance
AMSTERDAM, July 09, 2024 BUSINESS WIRE )--VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, announces the appointment of Adam Rosenberg as the new Chair of the Board. Boston-based Mr Rosenberg brings over 20 years of experience in building and leading life sciences companies, primarily in the neuroscience space. He replaces Dr Carlo Incerti who is stepping down from the company's board. The appointment comes at a pivotal time for VectorY as the company advances towards clinical development with a pipeline of strongly differentiated vectorized antibody treatments for neurodegenerative disorders. "As we welcome Adam to VectorY as Chair of the Board, I would also like to thank Carlo for his leadership, guidance and dedication to VectorY since our founding," commented Sander van Deventer, Founder and CEO of VectorY "Adam is a seasoned biotech and independent executive with a proven track reco
Show less
Read more
Impact Snapshot
Event Time:
ELYM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELYM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELYM alerts
High impacting Eliem Therapeutics, Inc news events
Weekly update
A roundup of the hottest topics
ELYM
News
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation SummitGlobeNewswire
- Eliem Therapeutics Announces Additions to its Leadership TeamGlobeNewswire
- Eliem Therapeutics Reports Second Quarter Financial Results [Yahoo! Finance]Yahoo! Finance
- Eliem Therapeutics Reports Second Quarter Financial ResultsGlobeNewswire
- BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors [Yahoo! Finance]Yahoo! Finance
ELYM
Sec Filings
- 9/20/24 - Form 4
- 8/27/24 - Form 8-K
- 8/26/24 - Form 4
- ELYM's page on the SEC website